Related by context. All words. (Click for frequent words.) 64 triacylglycerol concentrations 63 antioxidant supplementation 63 serum triglycerides 63 hyperglycaemia 62 glycated hemoglobin levels 62 triglyceride concentrations 62 fasting triglycerides 62 glycemic variability 62 serum leptin 62 Epidemiologic studies 62 vildagliptin 62 dietary carbohydrate 62 triglyceride lowering 61 SGPT 61 glycosylated hemoglobin HbA1c 61 hematological parameters 61 postprandial glucose levels 61 hepatic fibrosis 61 glomerular filtration 61 elevated fasting glucose 61 probiotic supplementation 61 cardiac autonomic 61 EDARBI 61 adiponectin concentrations 61 postprandial glycemia 61 Subgroup analyzes 61 AST ALT 61 prostate carcinogenesis 61 abnormal glucose metabolism 61 plasma renin activity 61 serum lipid levels 61 serum urate levels 60 plasma lipid 60 cardioprotective effects 60 blood glucose concentrations 60 insulin sensitizing 60 adiponectin levels 60 serum potassium 60 inhaled glucocorticoids 60 hemoglobin A1c HbA1c 60 lipid abnormalities 60 serum phosphate levels 60 serum lipid 60 unmeasured confounding 60 lipid parameters 60 red clover isoflavones 60 thyrotropin 60 induced hypoglycemia 60 HOMA IR 60 CYP#C# genotype 60 serum concentrations 60 serum PTH 60 Tasigna prolongs 60 serum bicarbonate 60 hsCRP 59 myopathy rhabdomyolysis 59 homocysteine concentrations 59 G. biloba 59 INVEGA ® 59 clomipramine 59 atherogenic dyslipidemia 59 macrovascular disease 59 stimulated insulin secretion 59 nonfasting 59 β blockers 59 Lipoic acid 59 intranasal corticosteroids 59 tumor hypoxia 59 lowering blood glucose 59 oral antidiabetes 59 Observational studies 59 Alpha lipoic acid 59 inorganic nitrate 59 fructose intake 59 coinfected patients 59 HbA1C 59 RBP4 levels 59 antiplatelet medications 59 LDL cholesterol concentrations 59 platelet reactivity 59 abdominal adiposity 59 HER2 expression 59 STAT3 signaling 59 serum lipids 59 HbA1C levels 59 NPH insulin 59 improves insulin sensitivity 59 cardiac conduction 59 QTc intervals 59 coadministration 59 transferrin saturation 59 antiangiogenic therapy 59 elevated triglyceride levels 59 exhaled nitric oxide 59 dyslipidaemia 59 albumin excretion 59 Singh Manoux 59 Glucocorticoids 59 pharmacologic intervention 59 clinically meaningful reductions 59 Hypoglycaemia 59 glargine 59 plasma lipids 59 lipoprotein profile 59 colorectal adenoma 58 fructosamine 58 antidiabetic medication 58 HER2 overexpression 58 OGTT 58 thromboxane A2 58 riociguat 58 impaired insulin secretion 58 neurodevelopmental outcome 58 elevated homocysteine 58 neuroregenerative 58 metabolic disturbances 58 IUGR 58 Fasting glucose 58 abnormal glucose tolerance 58 Cardiorespiratory fitness 58 c reactive protein 58 mGluR5 inhibition 58 Suicidal ideation 58 metformin Glucophage 58 dietary folate 58 ischemic tissues 58 intracerebral haemorrhage 58 aminotransferases 58 peptide YY 58 Combination therapy 58 peripheral insulin sensitivity 58 creatine supplementation 58 fasting glucose levels 58 silent myocardial ischemia 58 ® pioglitazone HCl 58 K ras mutations 58 Glycemic load 58 thiazide diuretics 58 RISPERDAL ® 58 MAGE A3 ASCI 58 impaired glucose metabolism 58 PlGF 58 hsCRP levels 58 dyslipidemias 58 pharmacodynamic properties 58 plasma leptin 58 inflammatory biomarkers 58 postprandial glucose 58 growth hormone secretion 58 topical calcineurin inhibitors 58 Calcium intake 58 glycemia 58 metabolite concentrations 58 IGFBP 3 58 serum BDNF 58 cardioprotection 58 receptor subtypes 58 LV dysfunction 58 lipoprotein levels 58 aldosterone antagonists 58 serum GGT 58 Intravenous immunoglobulin 58 glycated hemoglobin HbA1c 58 antiandrogens 58 Zevalin consolidation 58 pathophysiological mechanisms 58 creatinine ratio 58 plasma homocysteine levels 58 T2DM 58 CYP#A# substrate 58 serum retinol 58 antihypertensive therapy 58 elevated blood glucose 58 ATACAND 58 zafirlukast 58 somatostatin analog 58 renoprotective 58 CaPre ™ 58 interleukin IL -# 58 Insulin detemir 58 Cholesterol lowering 57 hematopoietic cancers 57 thiopurine 57 lipoprotein profiles 57 T1DM 57 benfotiamine 57 hyperphenylalaninemia HPA due 57 EEG abnormalities 57 glycosylated hemoglobin levels 57 creatinine clearance CrCl 57 Lantus insulin 57 Triglyceride levels 57 urinary excretion 57 poor metabolizers 57 reboxetine 57 Hp2 2 57 microalbuminuria 57 shorter telomere length 57 ACTOS ® 57 Hb A1C 57 metabolic parameters 57 diabetic kidney 57 baseline HbA1c 57 glycogen synthesis 57 antioxidative 57 antidiabetic medications 57 beta carotene supplementation 57 plasma triglycerides 57 Magnesium deficiency 57 waist circumference WC 57 serum uric acid 57 folic acid vitamin B# 57 hyperhomocysteinemia 57 hypovitaminosis D 57 GABRA2 57 basal bolus regimen 57 Fasting blood glucose 57 Nonalcoholic fatty liver 57 nonalcoholic steatohepatitis NASH 57 NUCYNTA ™ 57 statin medications 57 angiotensin II receptor blockers 57 Hypotension 57 oral antidiabetic drugs 57 remnant lipoproteins 57 lowers triglycerides 57 pancreatic polypeptide 57 CLA supplementation 57 selenium supplementation 57 Thyroid disorders 57 El Sohemy 57 Abbott Trilipix 57 Plant sterols 57 prolonged QT interval 57 arterial calcification 57 myocardial ischaemia 57 diabetes dyslipidemia 57 glycogen metabolism 57 dose proportionality 57 Warfarin Coumadin 57 intensive statin therapy 57 bile acid metabolism 57 flavanol rich foods 57 overt nephropathy 57 hepatotoxic 57 CTAP# Capsules 57 selective modulator 57 Calcium absorption 57 cardiovascular morbidity 57 elevated LDL cholesterol 57 intact parathyroid hormone 57 oxidized cysteine 57 prostate cancer CaP 57 dosing frequency 57 STRIDE PD 57 r hGH 57 airway hyperresponsiveness 57 subclinical atherosclerosis 57 visceral adiposity 57 lactose malabsorption 57 REMINYL ® 57 insulin resistance precursor 57 CVD mortality 57 NNT = 57 albumin excretion rate 57 glulisine 57 diabetes mellitus DM 57 antitumor effect 57 plasma lipoprotein 57 glucose homeostasis 57 guanfacine 57 psoriatic arthritis PsA 57 rheumatoid arthritis osteoarthritis ankylosing 57 CVD cardiovascular disease 57 anticholinergic agents 57 nonfasting triglyceride levels 57 pharmacodynamic parameters 57 neuroinflammatory 57 glucose insulin 57 hydroxy vitamin D 57 Skin sterol 57 obstructive coronary artery 57 serum triglyceride levels 57 pancreas secretes insulin 57 serum homocysteine 57 Endothelial function 57 HIV coinfected 57 Undesirable alterations 57 bezafibrate 57 Endothelial dysfunction 57 serum folate concentrations 57 dysglycemia 57 Clusterin 57 NNRTI resistant virus 57 GH deficiency 57 trans palmitoleate 57 HDL2 57 anticonvulsant medications 57 albuminuria 57 Calorie restriction 57 neuropsychiatric symptoms 57 FBPase 57 atopic disorders 57 Soy isoflavones 57 potentially modifiable 57 Caloric restriction 57 tryptase 57 NIASPAN 57 Calorie intake 57 nondiabetics 57 IgG4 57 Cognitive impairment 57 lactate dehydrogenase LDH 57 oral FTY# 57 glycaemia 57 EXJADE 57 non ulcer dyspepsia 57 hyperinsulinemia 57 HIV tropism 57 chemoprotective 57 chromium supplementation 57 selectively inhibited 57 bronchial hyperresponsiveness 57 ACh 57 serum biomarkers 57 lipid profiles 57 echocardiographic parameters 57 chlamydial infection 56 anti JCV antibodies 56 serum creatinine levels 56 stimulates insulin secretion 56 fluoroquinolone resistance 56 acute bronchospasm 56 apneic episodes 56 PR interval prolongation 56 HPA axis 56 Selenium supplements 56 Lactobacillus KW 56 bronchopulmonary dysplasia BPD 56 Myfortic 56 NPM1 mutation 56 Mg Uk 56 B7 H3 56 INVEGA ™ 56 MEVACOR 56 serum cortisol 56 potassium sparing diuretics 56 Pharmacokinetic parameters 56 antidiabetic drugs 56 serum phosphate 56 sulfonylurea metformin 56 tissue oxygenation 56 G6PD deficiency 56 Chronic pancreatitis 56 Thiazolidinediones 56 Mechanistic studies 56 maximally tolerated 56 antidepressant efficacy 56 gallstone disease 56 convergent validity 56 gestational diabetes mellitus 56 primary aldosteronism 56 triacylglycerol 56 VAPRISOL 56 biphasic insulin aspart 56 Stop Hypertension diet 56 receptor inhibitor 56 extrapyramidal symptoms 56 serum albumin 56 parasitemia 56 recurrent VTE 56 coagulation abnormalities 56 plasma homocysteine 56 PreDx DRS 56 proNGF 56 antiresorptive 56 insulin sensitizing drug 56 contrast induced nephropathy 56 symptom flare ups 56 hypercholesterolaemia 56 DHEA supplementation 56 nonpharmacologic interventions 56 metformin sulfonylureas 56 serum calcium levels 56 Pischon 56 #dhTxB# 56 adipokines 56 glitazones 56 plasma folate 56 Tschöp 56 erythropoietic 56 serum IGF 56 acamprosate 56 endometrial hyperplasia 56 soluble CD# ligand 56 CSF Tf 56 autoantibody levels 56 analgesic effects 56 atherosclerotic vascular disease 56 UCP2 56 multivariate adjustment 56 acetyl L carnitine 56 dopaminergic therapy 56 type2 diabetes 56 SIBO 56 Relapsing remitting MS 56 antidiabetic drug 56 relapsed MM 56 natriuretic peptides 56 degludec 56 dietary nitrate 56 Cystatin C 56 Christos Mantzoros 56 DPP4 56 COPD exacerbations 56 serum insulin 56 phylloquinone 56 reduce serum phosphate 56 microangiopathy 56 EGFR tyrosine kinase inhibitors 56 adrenal suppression 56 serum calcium 56 CP CPPS 56 fat hormone leptin 56 nonnucleoside reverse transcriptase inhibitors 56 Sitagliptin 56 Gliclazide 56 iPTH 56 intracellular uptake 56 thiazide 56 metabolic acidosis 56 incretin 56 L methionine 56 CETP gene 56 APTIVUS r 56 pharmacodynamic PD 56 abnormal lipid 56 Univariate analysis 56 hypoglycemic episodes 56 corrected QT interval 56 8 OHdG 56 UCP1 56 choline intake 56 statins cholesterol lowering 56 anti androgen 56 Lp PLA 2 56 monosaccharide 56 troponin T 56 HMG CoA reductase inhibitors 56 folate concentrations 56 pioglitazone HCl 56 non cirrhotic portal 56 serum phosphorus 56 PYY #-# 56 hyperalgesia 56 Flavanols 56 dietary glycemic index 56 tHcy 56 cerebral microbleeds 56 menaquinone 7 56 metabolic abnormalities 56 sulphonylureas 56 leukotriene receptor antagonist 56 insulin sensitization 56 estrogen metabolism 56 Kalantar Zadeh 56 folate supplementation 56 lipid levels 56 Tonalin ® CLA 56 autonomic dysfunction 56 vitamin B# folic acid 56 insulin deficiency 56 activate AMPK 56 allergic airway inflammation 56 paroxetine Paxil 56 Avandia Actos 56 Masimo SpHb 56 CaPre TM 56 A1c levels 56 Darapladib 56 comorbid disorders 56 topical NSAIDs 56 apolipoprotein B 56 Sumatriptan OS 56 cMET 56 conditional logistic regression 56 Bacterial vaginosis 56 antimetabolites 56 salmeterol fluticasone 56 leukotriene receptor antagonists 56 IV bisphosphonates 56 QTc prolongation 56 PLX STROKE targeting 56 pharmacokinetic interactions 56 Mild hypothermia 56 HDL cholesterol triglycerides 56 peptide YY PYY 56 lipid lowering therapy 56 nutritional supplementation 56 TPMT 56 APOE genotype 56 cholesterol HDL cholesterol 56 TCF#L# 56 effector function 56 estimated GFR 56 insulin secretagogue 56 cardiac insufficiency 56 systemic corticosteroid 56 paricalcitol 56 serum vitamin D 56 vascular dysfunction 56 biologic plausibility 56 MetS 56 tonsillar hypertrophy 56 adrenal function 56 EBV infection 56 subclinical inflammation 56 recurrent miscarriage 56 stratifying patients 56 transaminase levels 56 urinary albumin excretion 56 iron chelators 56 E. faecalis 56 D dimer 56 insulin analogues 56 serotonin synthesis 56 ginkgo biloba extract 56 cocoa polyphenols 56 silibinin 56 BENICAR HCT 56 gemifloxacin 56 trans palmitoleic acid 56 fosamprenavir 56 oral antidiabetic medication 56 thalidomide Thalomid 55 SSc 55 Vitamin D supplementation 55 anti androgens 55 hydrolyzed formula 55 dietary antioxidants 55 olmesartan 55 antihypertensive drugs 55 tau phosphorylation 55 Elevated triglycerides 55 symptomatic VTE 55 atypical antipsychotic medications 55 subclinical hypothyroidism 55 novel VDA molecule 55 HbA 1c 55 6 phosphate dehydrogenase 55 plasma fibrinogen 55 hydroxychloroquine 55 genetic polymorphisms 55 systolic hypertension 55 Lp PLA2 55 maintaining cardiorespiratory fitness 55 TRAIL induced apoptosis 55 secondary hyperparathyroidism 55 Cinnulin PF 55 HbA 1c levels 55 overactive bladder symptoms 55 urine albumin 55 serum markers 55 lipoprotein metabolism 55 fermentable carbohydrates 55 somatostatin 55 central adiposity 55 cyclic AMP cAMP 55 Detrol Detrol LA 55 TNFalpha 55 PNH patients 55 oxcarbazepine 55 sitosterol 55 Antidepressant medications 55 macroalbuminuria 55 postprandial insulin 55 serum cholesterol 55 cardio protective 55 insulin resistance syndrome 55 CYP#C# [001] 55 Akt activation 55 fatty acid oxidation 55 tipranavir ritonavir 55 isolated systolic hypertension 55 atherogenic 55 fibrotic disease 55 differential gene expression 55 rHuPH# 55 seropositivity 55 riboflavin vitamin B2 55 thiazolidinedione TZD 55 multivitamin supplementation 55 Genetic variants 55 BMI percentiles 55 Diamyd r vaccine 55 airway responsiveness 55 tumor subtypes 55 cardiac troponin T 55 elevated triglycerides 55 inhibiting COX 55 unmeasured factors 55 torsade de pointes 55 beta sitosterol 55 Pioglitazone 55 periodontal infection 55 non pharmacological interventions 55 Campylobacter spp 55 pharmacokinetic PK profile 55 Cardiotoxicity 55 Haptoglobin 55 thiazides 55 menaquinone 55 hemoglobin A1c levels 55 inducible nitric oxide synthase 55 alanine aminotransferase ALT 55 alkalosis 55 Creatinine 55 immune reconstitution syndrome 55 breast endometrial 55 equol producers 55 colorectal carcinogenesis 55 β carotene 55 LRP5 55 glucose lowering 55 underlying pathophysiology 55 atorvastatin #mg 55 receiving VELCADE 55 SHBG levels 55 opioid analgesia 55 colesevelam HCl 55 hepatic glucose production 55 Genetic predisposition 55 prognostic marker 55 FOSRENOL ® 55 plasma glucose 55 Randomised controlled trials 55 thyroid deficiency 55 ADAGIO study 55 β blocker 55 procalcitonin 55 hyperglycemia 55 carbohydrate absorption 55 hypocalcemia 55 ELISpot 55 trastuzumab Herceptin ® 55 Proteinuria 55 residual confounding 55 ULORIC 55 trigylcerides 55 diabetic cardiomyopathy 55 beta. 55 Carbohydrate intake 55 anovulatory infertility 55 venlafaxine XR 55 SUSTENNA TM 55 pharmacologic stress testing 55 induce orthostatic hypotension 55 pure fructose 55 paroxetine sertraline 55 hemoglobin hematocrit 55 primidone 55 mild renal insufficiency 55 ALT elevation 55 anaphylactic reactions bronchospasm 55 LAB CGRP 55 hypertensives 55 metastatic neuroendocrine tumors 55 vitamin D inadequacy 55 ghrelin concentrations 55 spirometric 55 Aldosterone 55 intima media thickness 55 beta carotene lycopene 55 nonfasting triglycerides 55 Oleic acid 55 soy isoflavone 55 KIF6 carriers 55 Ketosis 55 DFMO 55 abacavir lamivudine 55 Prostate specific antigen 55 immune globulins 55 ULTRAM ER 55 hydroxyvitamin D levels 55 creatinine levels 55 thromboembolic complications 55 unmeasured confounders 55 HIV HCV coinfected 55 plant sterol esters 55 androgen depletion 55 gastric cardia 55 antiarrhythmic drug 55 canakinumab 55 stone formers 55 CIMZIA ™ 55 p# Shc 55 disulfiram 55 severe exacerbations 55 serum urate 55 PTH secretion 55 conjugated linoleic acids 55 PSADT 55 elevated CRP 55 mitochondrial toxicity 55 aldosterone hormone 55 salmeterol HFA MDI 55 #OHD levels 55 Teriflunomide 55 inhibin B 55 #mg doses [002] 55 intermittent hypoxia 55 left ventricular diastolic 55 kidney urologic 55 Drospirenone 55 PROCRIT ® 55 Trinovin 55 chronic lyme 55 Hypertriglyceridemia 55 FeNO 55 Statin therapy 55 periprocedural MI 55 endogenous opioid 55 acarbose 55 alanine aminotransferase 55 mTOR inhibition 55 neuroprotective properties 55 dietary carbohydrates 55 acute humoral rejection 55 fat oxidation 55 abrupt discontinuation 55 hemodynamic variables 55 glycated hemoglobin 55 cholecystokinin CCK 55 lipid lowering medications 55 thyroid stimulating hormone 55 immune modulatory 55 hypertensive patients 55 biochemical abnormalities 55 adrenocortical cancer 55 hypertensive rats 55 p# activation 55 plasma kallikrein 55 QT interval prolongation 55 pyridostigmine 55 ABCB1 55 Pseudomonas aeruginosa infections 55 carotid plaques 55 calcium excretion 55 aspartame sucralose 55 palmitic acid 55 preclinically 55 coinfection 55 Nicotinamide 55 renal toxicity 55 ubiquinol 55 IgE antibody 55 Valproic acid 55 adipokine 55 IGFBP 55 CSF biomarkers 55 Elevated serum 55 AGHD 55 NAbs 55 antiarrhythmic 55 noncardiovascular mortality 55 MAXALT 55 Sugar sweetened beverages 55 reactive hypoglycemia 55 triiodothyronine 55 bexarotene 55 Subgroup analysis 55 Tardive dyskinesia 55 chronic thromboembolic pulmonary 55 rimonabant #mg 55 selenium intake 55 gliclazide 55 dietary DHA 55 Bracketed figures 55 prognostically 55 nondiabetic patients 55 N glycan 55 DULERA 55 TLE3 55 gastrointestinal absorption 55 SNT MC# 55 insulin detemir 55 pleiotropic effects 55 Uncontrolled hypertension 55 virological response 55 EtOH 55 premenstrual syndrome PMS 55 atherothrombotic disease 55 pulmonary exacerbations 55 Pharmacokinetic studies 55 macrovascular events 55 abnormal lipids 54 chloride secretion 54 dose dependently 54 hepatic steatosis 54 triglyceride concentration 54 CLBP 54 Viral load 54 angiographically 54 tumor histology 54 NSAIDs aspirin 54 Listeria infections 54 TMP SMX 54 Depressive symptoms 54 hormone adiponectin 54 insulin analogs 54 magnesium supplementation 54 pharmacokinetic interaction 54 Symptom severity 54 sedating medications 54 carotid bruit 54 Multivariate analyzes 54 central corneal thickness 54 prognostic indicators 54 hypersensitivity allergic reactions 54 Topiramate 54 pentoxifylline 54 cardioprotective effect 54 elevated uric acid 54 sonographic diagnosis 54 sCJD 54 teriflunomide 54 lipogenesis 54 alkaline phosphatase 54 Bystolic nebivolol 54 Immunohistochemical analysis 54 serum estradiol 54 induced oxidative stress 54 insulin aspart 54 HMGA1 54 isoproterenol 54 testosterone supplementation 54 sertraline Zoloft 54 VKORC1 54 sedating antihistamine 54 foveal thickness 54 d l leucovorin 54 surrogate marker 54 cerebral oxygenation 54 #ß 54 impaired endothelial 54 dopamine antagonists 54 nondiabetic subjects 54 intestinal permeability 54 glucose uptake 54 HMG CoA reductase 54 Ascherio 54 nonpharmacologic 54 alpha7 NNR 54 actigraphy 54 Epidemiological studies 54 SpO 2 54 serum glucose 54 menadione 54 mmol l 54 oxaliplatin Eloxatin 54 pituitary hormone 54 bioavailable testosterone 54 clusterin 54 pyridoxine 54 factor TNF 54 ionotropic 54 CYP #D# 54 urinary calcium 54 cortisol concentrations 54 plasminogen activators 54 lipohypertrophy 54 Phospha E R 54 hypercholesterolemia 54 IPAH 54 fat vegan diet 54 Peptide YY 54 specific IgE 54 LDL HDL 54 Angiotensin converting enzyme 54 immune modulating 54 elevated serum creatinine 54 serum aminotransferase levels 54 HbA1c levels 54 serum IgE 54 oversulfated version 54 urinary cortisol 54 Unsaturated fats 54 antidiabetic agents 54 viral kinetics 54 umami savory 54 PROCHYMAL 54 dietary modification 54 SAMe 54 tranylcypromine 54 insulin sensitizers 54 severe hypoglycaemia 54 oral antidiabetic agents 54 folate folic acid 54 improves glycemic 54 ADPKD 54 glucocorticoid receptors 54 nonpregnant adults 54 immunosuppressive therapies 54 intracranial hypertension 54 sustained virological response 54 folate intake 54 extracellular dopamine 54 immunological responses 54 Thiamine 54 SR B1 54 parkinsonian symptoms 54 hemoglobin A1C HbA1C 54 androgen depletion therapy 54 cinacalcet 54 genotypic resistance 54 chronic prostatitis chronic 54 Mg Usa 54 vasodilatation 54 pharmacologic treatments 54 vidofludimus 54 Homocysteine levels 54 Randomized trials 54 fatty acid supplementation 54 MYLOTARG 54 L lysine 54 hypercholesterolemic patients 54 Telintra 54 MDRD equation 54 TNF antagonist 54 B vitamin supplementation 54 tiagabine 54 beta carotene supplements 54 hyperprolactinemia 54 thyroglobulin 54 lowering triglyceride levels 54 PITX2 methylation 54 postoperative AF 54 comorbid conditions 54 Meridia sibutramine 54 isoflavone supplement 54 co trimoxazole 54 neutrophil gelatinase associated lipocalin 54 monoamine oxidase inhibitors 54 corticosteroid dose 54 Insulin Delivery Systems 54 fasting plasma 54 androgen receptor pathway 54 Serum calcium 54 candidemia 54 digestive disturbances 54 Sodium bicarbonate 54 von Willebrand factor 54 dyslipidemia hypertension 54 FGFs 54 familial predisposition 54 neuropeptide Y NPY 54 amylin 54 pharmacodynamic markers 54 cardiometabolic risk 54 Bergenstal 54 nephrotoxicity 54 Apidra ® 54 proinflammatory cytokine 54 adjuvant systemic 54 Perforomist ™ Inhalation Solution 54 Aggrastat ® tirofiban hydrochloride 54 lowers blood glucose 54 Nocturia 54 KRAS mutation status 54 nutrigenomic 54 prolactin elevation 54 rhTSH 54 developmental neurotoxicity 54 hormones leptin 54 endothelial function 54 balsalazide 54 serum parathyroid hormone 54 pharmacologic stress 54 leptin deficient mice 54 LDL oxidation 54 linoleic acids 54 surrogate markers 54 MDRD 54 Liver enzymes 54 polyp recurrence 54 alfuzosin 54 IgE antibodies 54 citicoline 54 glycosylated hemoglobin 54 pCR 54 bronchodilatory 54 ß blockers 54 SCr 54 ritonavir boosted 54 pathogenic mechanisms 54 hypoglycemia unawareness 54 squamous cell lung cancer 54 heterozygotes 54 hexose